Transfer of allograft specific tolerance requires CD4+CD25 +T cells but not interleukin-4 or transforming growth factor-β and cannot induce tolerance to linked antigens

Transplantation

Volumn 83, Issue 8, 2007, Pages 1075-1084

  Hall, Bruce M ^a,e   Plain, Karren M ^a   Verma, Nirupama D ^a   Tran, Giang T ^a   Boyd, Rochelle ^a   Robinson, Catherine M ^a   Nicolls, Mark R ^b   Berger, Manuela E ^c   Nomura, Masaru ^d   Hodgkinson, Suzanne J ^d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF COLORADO   (United States)

^c PFIZER INC   (United States)

^d HOKKAIDO UNIVERSITY   (Japan)

^e Australian Technology Park   (Australia)

Author keywords

Cardiac transplantation; Linked suppression; T cells; Th1 Th2; Tolerance suppression anergy

Indexed keywords

CYTOKINE; INTERLEUKIN 4; MESSENGER RNA; MONOCLONAL ANTIBODY CD3; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN PRESENTING CELL; ARTICLE; BAGG ALBINO MOUSE; CD4+ CD25+ T LYMPHOCYTE; GENE EXPRESSION; HEART TRANSPLANTATION; LEWIS RAT; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SINGLE DRUG DOSE; SKIN GRAFT; TH1 CELL; TH2 CELL;

AGING; ANIMALS; ANIMALS, NEWBORN; ANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; HEART TRANSPLANTATION; IMMUNE TOLERANCE; INTERLEUKIN-4; MICE; RATS; RNA, MESSENGER; SKIN TRANSPLANTATION; SURVIVAL RATE; T-LYMPHOCYTE SUBSETS; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HOMOLOGOUS;

EID: 34247492738     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000259553.66185.2f     Document Type: Article

References (86)

1. Hall BM. Mechanisms of induction of tolerance to organ allografts. Crit Rev Immunol 2000; 20: 267.
2. Batchelor JR, Welsh KI. Mechanisms of enhancement of kidney allograft survival. A form of operational tolerance. Br Med Bull 1976; 32: 113.
3. + suppressor T cells that are not dependent upon IL-4. J Immunol 1998; 161: 5147.
4. Hall BM, Jelbart ME, Gurley KE, Dorsch SE. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells. J Exp Med 1985; 162: 1683.
5. Nagao T, White DJG, Calne RY. Kinetics of unresponsiveness induced by a short course of cyclosporin A. Transplantation 1982; 33: 31.
6. Pearce NW, Berger MF, Gurley KE, et al. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. VI. In vitro alloreactivity of T cell subsets from rats with long-surviving allografts. Transplantation 1993; 55: 380.
7. Ilstad ST, Wren SM, Bluestone JA, et al. Characterization of mixed allogeneic chimeras: Immunocompetence, in vitro reactivity, and genetic specificity of tolerance. J Exp Med 1985; 162: 231.
8. Thomas JM, Carver M, Cunningham P, et al. Promotion of incompatible allograft acceptance in rhesus monkeys given post transplant antithymocyte globulin and bone marrow. II. Effects of adjuvant immunosuppressive drugs. Transplantation 1989; 47: 209.
9. Hall BM. Mechanisms maintaining enhancement of allografts. I. Demonstration of a specific suppressor cell. J Exp Med 1985; 161: 123.
10. + suppressor cell and its mechanisms of action. J Exp Med 1990; 171: 141.
11. Hall BM, Roser BJ, Dorsch SE. A model for study of the cellular mechanisms that maintain long-term enhancement of cardiac graft survival. Transplant Proc 1979; 11: 958.
12. Qin S, Cobbold SP, Pope H, et al. "Infectious" transplantation tolerance. Science 1993; 259: 974.
13. + suppressor cell on the presence of alloantigen and cytokines, including interleukin-2. Transplantation 1993; 55: 374.
14. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057.
15. + T cells as regulators of alloimmune responses. Transplant Proc 2001; 33: 163.
16. + T cells via a CD30-dependent mechanism. J Clin Invest 2004; 113: 310.
17. 3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001; 167: 1945.
18. Hara M, Kingsley CI, Niimi M, et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001; 166: 3789.
19. + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 2002; 168: 1080.
20. + regulatory T cells: Their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001; 182: 18.
21. Sawitzki B, Kingsley CI, Oliveira V, et al. IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J Exp Med 2005; 201: 1925.
22. + immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 2001; 193: 1311.
23. + T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J Immunol 2002; 169: 5401.
24. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199.
25. + immunoregulatory T cells: New therapeutics for graft-versus-host disease. J Exp Med 2002; 196: 401.
26. + regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 2002; 196: 389.
27. + T lymphocytes. Blood 2004; 103: 4216.
28. + immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002; 99: 3493.
29. Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151.
30. Shevach EM. Regulatory T cells in autoimmmunity. Annu Rev Immunol 2000; 18: 423.
31. - regulatory cells mediate dominant transplantation tolerance. J Immunol 2002; 168: 5558.
32. Chen ZK, Cobbold SP, Waldmann H, Metcalfe S. Amplification of natural regulatory immune mechanisms for transplantation tolerance. Transplantation 1996; 62: 1200.
33. Davies JD, Leong LY, Mellor A, et al. T cell suppression in transplantation tolerance through linked recognition. J Immunol 1996; 156: 3602.
34. + regulatory T cells generated by exposure to a model protein antigen-specific reactivation in vivo is critical for bystander regulation. Blood 2005; 105: 4871.
35. Wise MP, Bemelman F, Cobbold SP, Waldmann H. Linked suppression of skin graft rejection can operate through indirect recognition. J Immunol 1998; 161: 5813.
36. + T cells. J Immunol 2004; 173: 6526.
37. - T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 2004; 172: 5149.
38. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198: 1875.
39. + T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J Exp Med 2002; 196: 1335.
40. + regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 2001; 194: 629.
41. Bickerstaff AA, VanBuskirk AM, Wakely E, Orosz CG. Transforming growth factor-beta and interleukin-10 subvert alloreactive delayed type hypersensitivity in cardiac allograft acceptor mice. Transplantation 2000; 69: 1517.
42. Josien R, Douillard P, Guillot C, et al. A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance. J Clin Invest 1998; 102: 1920.
43. + T-cell inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389: 737.
44. - thymocytes. J Exp Med 1999; 189: 279.
45. Bickerstaff AA, Wang J-J, Pelletier RP, Orosz CG. Murine Renal Allografts: Spontaneous acceptance is associated with regulated T cell-mediated immunity. J Immunol 2001; 167: 4821.
46. Miller A, Lider O, Roberts AB, et al. Suppressor T cells generated by oral tolerisation to myelin basic protein suppress both in vitro and in vivo immune responses by release of transforming growth factor beta after antigen specific triggering. Proc Natl Acad Sci USA 1992; 89: 421.
47. He XY, Chen J, Verma N, et al. Treatment with interleukin-4 prolongs allogeneic neonatal heart graft survival by inducing T helper 2 responses. Transplantation 1998; 65: 1145.
48. Takeuchi T, Lowry RP, Konieczny B. Heart allografts in murine systems. The differential activation of Th2-like effector cells in peripheral tolerance. Transplantation 1992; 53: 1281.
49. Takeuchi T, Ueki T, Sunaga S, et al. Murine Interleukin 4 transgenic heart allograft survival prolonged with down-regulation of Th1 cytokine mRNA in grafts. Transplantation 1997; 64: 152.
50. Plain KM, Chen J, Merten S, et al. Induction of specific tolerance to allografts in rats by therapy with non-mitogenic, non-depleting anti-CD3 monoclonal antibody: association with Th2 cytokines not anergy. Transplantation 1998; 67: 605.
51. Plain KM, Fava L, Spinelli A, et al. Induction of tolerance with nondepleting anti-CD4 monoclonal antibodies is associated with down-regulation of Th2 cytokines. Transplantation 1997; 64: 1559.
52. Levy AE, Alexander JW. Administration of intragraft interleukin-4 prolongs cardiac allograft survival in rats treated with donor-specific transfusion / cyclosporin. Transplantation 1995; 60: 405.
53. He XY, Verma N, Chen J, et al. IL-5 prolongs allograft survival by down regulating IL-2 and IFN-gamma cytokines. Transplant Proc 2001; 33: 703.
54. Bromberg JS. IL-10 immunosuppression in transplantation. Current Opin Immunol 1995; 7: 639.
55. Hackstein H, Kluter H, Fricke L, et al. The IL-4 receptor alpha-chain variant Q576R is strongly associated with decreased kidney allograft survival. Tissue Antigens 1999; 54: 471.
56. Nicolls MR, Aversa GG, Pearce NW, et al. Induction of long-term specific tolerance to allografts in rats by therapy with an anti-CD3-like monoclonal antibody. Transplantation 1993; 55: 459.
57. Chatenoud L. CD3-specific antibody-induced active tolerance: From bench to bedside. Nat Rev Immunol 2003; 3: 123.
58. Hall BM, Dorsch S, Roser B. The cellular basis of allograft rejection in vivo. I. The cellular requirements for first-set rejection of heart grafts. J Exp Med 1978; 148: 878.
59. - T cells determines rejection or tolerance. Transpl Immunol 2006; 15: 311.
60. + T cells. Eur J Immunol 1991; 21: 1187.
61. Lucas C, Bald LN, Fendly BM, et al. The autocrine production of transforming growth factor-beta 1 during lymphocyte activation. A study with a monoclonal antibody-based ELISA. J Immunol 1990; 145: 1415.
62. Aversa GG, Waugh JA, Hall BM. Characterization of a monoclonal antibody (A6) recognizing a unique epitope on restricted members of the leucocyte common antigen family, including CD45RO and CD45RB that identifies functional subsets of T cells. Cell Immunol 1994; 158: 314.
63. Hall BM, Dorsch SE. Cells mediating allograft rejection. Immunol Rev 1984; 77: 31.
64. + T cell subsets in low- and high-responder rat strains. J Immunol 1989; 143: 2828.
65. Penny MJ, Boyd RA, Hall BM. Role of T cells in the mediation of Heymann nephritis. ii. Identification of Th1 and cytotoxic cells in glomeruli. Kidney Int 1997; 51: 1059.
66. Plain KM, Boyd R, Verma N, et al. Transplant tolerance associated with a Th1 response and not broken by IL-4. IL-5 and TGF-beta blockade or Th1 cytokine administration. Transplantation 2007; 83: 764.
67. + cells. J Exp Med 1998; 188: 1775.
68. Merten S, Chen JC, Ha H, et al. The cellular basis of cardiac allograft rejection: VIII. Mechanisms underlying delayed allograft rejection in PVG C6-deficient rats. Transplantation 1998; 65: 1152.
69. Dallman MJ, Larsen CP, Morris PJ. Cytokine gene transcription in vascularised organ grafts: analysis using semi-quantitative polymerase chain reaction. J Exp Med 1991; 174: 493.
70. Hall BM, Gurley KE, Pearce NW, Dorsch SE. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. II. Sequential changes in alloreactivity of T cell subsets. Transplantation 1989; 47: 1030.
71. Morris PJ. Suppression of rejection of organ allografts by alloantibody. Immunol Rev 1980; 49: 93.
72. Dallman MJ, Wood KJ, Morris PJ. Specific cytotoxic T cells are found in non-rejected kidneys of blood transfused rats. J Exp Med 1987; 165: 566.
73. Bishop GA, Sun J, deCruz DJ, et al. Tolerance to rat liver allografts. III. Donor cell migration and tolerance- associated cytokine production in peripheral lymphoid tissue. J Immunol 1996; 156: 4925.
74. Bishop GA, Dharland AF, McCaughan GW. High-dose/activation-associated tolerance model for allografts: Lessons from spontaneous tolerance of transplanted livers. Current Opin Transplant Immunol 1999; 4: 58.
75. Farges O, Morris PJ, Dallman MJ. Spontaneous acceptance of rat liver allografts is associated with an early downregulation of intragraft interleukin-4 messenger RNA expression. Hepatology 1995; 21: 767.
76. Steiger J, Nickerson PW, Steurer W, et al. IL-2 knockout recipient mice reject islet cell allografts. J Immunol 1995; 155: 489.
77. Dai Z, Konieczny BT, Baddoura FK, Lakkis FG. Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice. J Immunol 1998; 161: 1659.
78. + T cells. J Immunol 1989; 143: 499.
79. + T cells: Evidence for two distinct regulatory mechanisms. Eur J Immunol 2001; 31: 1637.
80. Willerford D, Chen J, Ferry JA, et al. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 1995; 3: 521.
81. Papiernik M, de Moraes ML, Pontoux C, et al. Regulatory CD4 T cells: Expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int Immunol 1998; 10: 371.
82. Scully R, Qin S, Cobbold S, Waldmann H. Mechanisms in CD4 antibody-mediated transplantation tolerance: Kinetics of induction, antigen dependency and role of regulatory T cells. Eur J Immunol 1994; 24: 2383.
83. Spicer ST, Ha H, Boyd RA, et al. IL-4 therapy prevents the development of proteinuria in Active Heymann nephritis by inhibition of Tc1 cells. J Immunol 2001; 167: 3725.
84. Swain SL. CD4 T cell development and cytokine polarization: An overview. J Leukoc Biol 1995; 57: 795.
85. Groux H. Type 1 T-regulatory cells: Their role in the control of immune responses. Transplantation 2003; 75: 8S.
86. + T cells. J Exp Med 1996; 183: 2669.